{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T05:17:08Z","timestamp":1734671828159,"version":"3.32.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,19]]},"DOI":"10.7759\/cureus.75989","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:51:43Z","timestamp":1734598303000},"source":"Crossref","is-referenced-by-count":0,"title":["Macrotrabecular-Massive Hepatocellular Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Rapha\u00ebl","family":"Eftimie Spitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Manole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora","family":"Surdea-Blaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosmin","family":"Caraiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Burz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309465","article-title":"Trends of primary liver cancer incidence and mortality in the United States: a population-based study over the last four decades","volume":"19","author":"Adra S","year":"2024","unstructured":"Adra S, Alabrach Y, Hashem A, et al.. Trends of primary liver cancer incidence and mortality in the United States: a population-based study over the last four decades. PLoS One. 2024, 19:0309465. 10.1371\/journal.pone.0309465","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70526-z","article-title":"Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region","volume":"14","author":"Danpanichkul P","year":"2024","unstructured":"Danpanichkul P, Suparan K, Sukphutanan B, et al.. Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region. Sci Rep. 2024, 14:19544. 10.1038\/s41598-024-70526-z","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-019-0681-x","article-title":"The epidemiology of hepatocellular carcinoma in the USA","volume":"21","author":"Kim HS","year":"2019","unstructured":"Kim HS, El-Serag HB. The epidemiology of hepatocellular carcinoma in the USA. Curr Gastroenterol Rep. 2019, 21:17. 10.1007\/s11894-019-0681-x","journal-title":"Curr Gastroenterol Rep"},{"key":"ref5","article-title":"Digestive system tumours","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Digestive system tumours. World Health Organization, Geneva, Switzerland; 2019."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001289","article-title":"Macrotrabecular hepatocellular carcinoma: an aggressive subtype of hepatocellular carcinoma","volume":"43","author":"Jeon Y","year":"2019","unstructured":"Jeon Y, Benedict M, Taddei T, Jain D, Zhang X. Macrotrabecular hepatocellular carcinoma: an aggressive subtype of hepatocellular carcinoma. Am J Surg Pathol. 2019, 43:943-8. 10.1097\/PAS.0000000000001289","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.17998\/jlc.20.1.17","article-title":"Histopathological variants of hepatocellular carcinomas: an update according to the 5th edition of the WHO classification of digestive system tumors","volume":"20","author":"Kim H","year":"2020","unstructured":"Kim H, Jang M, Park YN. Histopathological variants of hepatocellular carcinomas: an update according to the 5th edition of the WHO classification of digestive system tumors. J Liver Cancer. 2020, 20:17-24. 10.17998\/jlc.20.1.17","journal-title":"J Liver Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02691-9","article-title":"Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma","volume":"70","author":"Liu LL","year":"2021","unstructured":"Liu LL, Zhang SW, Chao X, et al.. Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma. Cancer Immunol Immunother. 2021, 70:417-29. 10.1007\/s00262-020-02691-9","journal-title":"Cancer Immunol Immunother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro J","year":"2017","unstructured":"Calderaro J, Couchy G, Imbeaud S, et al.. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol. 2017, 67:727-38. 10.1016\/j.jhep.2017.05.014","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective","volume":"15","author":"Venook AP","year":"2010","unstructured":"Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010, 15:5-13. 10.1634\/theoncologist.2010-S4-05","journal-title":"Oncologist"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen CJ","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al.. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006, 295:65-73. 10.1001\/jama.295.1.65","journal-title":"JAMA"},{"key":"ref12","article-title":"Viral hepatitis B and hepatocellular carcinoma","volume":"74","author":"Michielsen P","year":"2011","unstructured":"Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastro-Enterol Belg. 2011, 74:4-8.","journal-title":"Acta Gastro-Enterol Belg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29762","article-title":"Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance","volume":"68","author":"Ziol M","year":"2018","unstructured":"Ziol M, Pot\u00e9 N, Amaddeo G, et al.. Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance. Hepatology. 2018, 68:103-12. 10.1002\/hep.29762","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061370","article-title":"Biomarkers in Hepatocellular Carcinoma: diagnosis, prognosis and treatment response assessment","volume":"9","author":"Pi\u00f1ero F","year":"2020","unstructured":"Pi\u00f1ero F, Dirchwolf M, Pess\u00f4a MG. Biomarkers in Hepatocellular Carcinoma: diagnosis, prognosis and treatment response assessment. Cells. 2020, 9:1370. 10.3390\/cells9061370","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.013","article-title":"Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications","volume":"74","author":"Rhee H","year":"2021","unstructured":"Rhee H, Cho ES, Nahm JH, et al.. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. J Hepatol. 2021, 74:109-21. 10.1016\/j.jhep.2020.08.013","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S364703","article-title":"Macrotrabecular-massive hepatocellular carcinoma: light and shadow in current knowledge","volume":"9","author":"Sessa A","year":"2022","unstructured":"Sessa A, Mul\u00e9 S, Brustia R, et al.. Macrotrabecular-massive hepatocellular carcinoma: light and shadow in current knowledge. J Hepatocell Carcinoma. 2022, 9:661-70. 10.2147\/JHC.S364703","journal-title":"J Hepatocell Carcinoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.601240","article-title":"Immune checkpoint inhibitors in the treatment of HCC","volume":"10","author":"Donisi C","year":"2020","unstructured":"Donisi C, Puzzoni M, Ziranu P, et al.. Immune checkpoint inhibitors in the treatment of HCC. Front Oncol. 2020, 10:601240. 10.3389\/fonc.2020.601240","journal-title":"Front Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3407","article-title":"FDA approval summary: atezolizumab plus bevacizumab for the treatment of patients with advanced unresectable or metastatic hepatocellular carcinoma","volume":"27","author":"Casak SJ","year":"2021","unstructured":"Casak SJ, Donoghue M, Fashoyin-Aje L, et al.. FDA approval summary: atezolizumab plus bevacizumab for the treatment of patients with advanced unresectable or metastatic hepatocellular carcinoma. Clin Cancer Res. 2021, 27:1836-41. 10.1158\/1078-0432.CCR-20-3407","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn RS","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, et al.. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020, 382:1894-905. 10.1056\/NEJMoa1915745","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100380","article-title":"Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS","volume":"3","author":"Cannella R","year":"2021","unstructured":"Cannella R, Dioguardi Burgio M, Beaufr\u00e8re A, et al.. Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS. JHEP Rep. 2021, 3:100380. 10.1016\/j.jhepr.2021.100380","journal-title":"JHEP Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-02989-x","article-title":"A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma","volume":"46","author":"Zhu Y","year":"2021","unstructured":"Zhu Y, Weng S, Li Y, et al.. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Abdom Radiol (NY). 2021, 46:3139-48. 10.1007\/s00261-021-02989-x","journal-title":"Abdom Radiol (NY)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel M","year":"2017","unstructured":"Schmittnaegel M, Rigamonti N, Kadioglu E, et al.. Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade. Sci Transl Med. 2017, 9:9670. 10.1126\/scitranslmed.aak9670","journal-title":"Sci Transl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323852-macrotrabecular-massive-hepatocellular-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:51:45Z","timestamp":1734598305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323852-macrotrabecular-massive-hepatocellular-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.75989","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}